共 58 条
[1]
Hanania NA(2011)Asthma in the elderly: current understanding and future research needs - a report of a National Institute on Aging (NIA) workshop J Allergy Clin Immunol 128 4-24
[2]
King MS(1986)Airway responsiveness to leukotriene C4 and D4 and to methacholine in patients with asthma and normal controls N Engl J Med 315 480-4
[3]
Braman SS(1999)Effect of inhaled leukotriene D4 on airway eosinophilia and airway hyperresponsiveness in asthmatic subjects Am J Respir Crit Care Med 159 1562-7
[4]
Saltoun C(1998)Montelukast, a once-daily leukotriene receptor antagonist, in the treatment of chronic asthma Arch Intern Med 158 1213-20
[5]
Wise RA(1999)Oral montelukast, inhaled beclomethasone, and placebo for chronic asthma Ann Intern Med 130 487-95
[6]
Enright P(1999)Montelukast added to inhaled beclomethasone in treatment of asthma. Montelukast/Beclomethasone additivity group Am J Respir Crit Care Med 160 1862-8
[7]
Adelroth E(2000)Effect of age on response to zafirlukast in patients with asthma in the Accolate clinical experience and pharmacoepidemiology trial (ACCEPT) Ann Allergy Asthma Immunol 84 217-25
[8]
Morris MM(2002)Loss of response to treatment with leukotriene receptor antagonists but not inhaled corticosteroids in patients over 50 years of age Ann Allergy Asthma Immunol 88 401-9
[9]
Hargreave FE(2012)Montelukast as a add-on therapy to inhaled corticosteroids in the treatment of severe asthma in elderly patients J Asthma 49 530-4
[10]
O’Byrne PM(2015)Addition of montelukast to low-dose inhaled corticosteroid leads to fewer exacerbations in older patients than medium-dose inhaled corticosteroid monotherapy Allergy, Asthma Immunol Res 7 440-6